These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Sensitive detection of transitional cell carcinoma of the bladder by microsatellite analysis of cells exfoliated in urine. Seripa D, Parrella P, Gallucci M, Gravina C, Papa S, Fortunato P, Alcini A, Flammia G, Lazzari M, Fazio VM. Int J Cancer; 2001 Nov 20; 95(6):364-9. PubMed ID: 11668518 [Abstract] [Full Text] [Related]
5. [Microsatellite instability in urine sediments from patients with transitional cell carcinoma of bladder and its clinical value]. Lü Y, Tang D, Yu L, Ding Y, Liu L, Guo Y. Zhonghua Wai Ke Za Zhi; 2000 Apr 20; 38(4):294-6. PubMed ID: 12828175 [Abstract] [Full Text] [Related]
10. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples. Dahse R, Utting M, Werner W, Schimmel B, Claussen U, Junker K. Int J Oncol; 2002 Jan 20; 20(1):107-15. PubMed ID: 11743649 [Abstract] [Full Text] [Related]
11. Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial [CEFUB]). van der Aa MN, Zwarthoff EC, Steyerberg EW, Boogaard MW, Nijsen Y, van der Keur KA, van Exsel AJ, Kirkels WJ, Bangma C, van der Kwast TH. Eur Urol; 2009 Mar 20; 55(3):659-67. PubMed ID: 18501499 [Abstract] [Full Text] [Related]
12. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment. Bartoletti R, Dal Canto M, Cai T, Piazzini M, Travaglini F, Gavazzi A, Rizzo M. Oncol Rep; 2005 Mar 20; 13(3):531-7. PubMed ID: 15706429 [Abstract] [Full Text] [Related]
15. Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue. Berger AP, Parson W, Stenzl A, Steiner H, Bartsch G, Klocker H. Eur Urol; 2002 May 20; 41(5):532-9. PubMed ID: 12074795 [Abstract] [Full Text] [Related]
16. Molecular urinary sediment analysis in patients with transitional cell bladder carcinoma. Dal Canto M, Bartoletti R, Travaglini F, Piazzini M, Lodovichi G, Rizzo M, Selli C. Anticancer Res; 2003 May 20; 23(6D):5095-100. PubMed ID: 14981972 [Abstract] [Full Text] [Related]
17. Molecular followup of newly diagnosed bladder cancer using urine samples. Shigyo M, Sugano K, Tobisu K, Tsukamoto T, Sekiya T, Kakizoe T. J Urol; 2001 Oct 20; 166(4):1280-5. PubMed ID: 11547058 [Abstract] [Full Text] [Related]
18. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma]. Fernández Gómez JM, García Rodríguez J, Escaf Barmadah S, Raigoso P, Rodríguez Martínez JJ, Allende MT, Casasola Chamorro J, Rodríguez Faba O, Martín Benito JL, Regadera Sejas FJ. Arch Esp Urol; 2002 Oct 20; 55(1):41-9. PubMed ID: 11957750 [Abstract] [Full Text] [Related]
19. Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: diagnostic review bias in the randomized, prospective CEFUB trial. van der Aa MN, Steyerberg EW, Bangma C, van Rhijn BW, Zwarthoff EC, van der Kwast TH. J Urol; 2010 Jan 20; 183(1):76-80. PubMed ID: 19913254 [Abstract] [Full Text] [Related]
20. Combinations of urine-based tumour markers in bladder cancer surveillance. Horstmann M, Patschan O, Hennenlotter J, Senger E, Feil G, Stenzl A. Scand J Urol Nephrol; 2009 Jan 20; 43(6):461-6. PubMed ID: 19903092 [Abstract] [Full Text] [Related] Page: [Next] [New Search]